Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-13 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-13 |
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-13 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-13 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-13 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-12 |
mRNA | LRRC37B | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |